Why do lean people with metabolic dysfunction-associated fatty liver disease (MAFLD) have higher mortality than their non-lean counterparts? 🤔 Research by the Storr Liver Centre at the @WestmeadInst has identified some reasons. #skyliver
🔗 https://hepatitissa.asn.au/communitynews/2024/12/thinner-not-better-with-mafld/
🔗 https://hepatitissa.asn.au/communitynews/2024/12/thinner-not-better-with-mafld/
Comments